# William R. Sellers

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/william-r-sellers/

## Facts

| Field | Value |
| --- | --- |
| Citations | 86,275 |
| Field | PI3K/AKT/mTOR signaling in cancer |
| h-index | 119 |
| i10-index | 207 |
| Last Known Institution | Broad Institute |
| OpenAlex ID | https://openalex.org/A5057346782 |
| ORCID iD | https://orcid.org/0000-0002-3539-9803 |
| Works | 830 |

## Researcher papers

- [<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy](https://scholariq.org/papers/i-egfr-i-mutations-in-lung-cancer-correlation-with-clinical-response-to/)
- [The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity](https://scholariq.org/papers/the-cancer-cell-line-encyclopedia-enables-predictive-modelling-of-anticancer/)
- [The landscape of somatic copy-number alteration across human cancers](https://scholariq.org/papers/the-landscape-of-somatic-copy-number-alteration-across-human-cancers/)
- [High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response](https://scholariq.org/papers/high-throughput-screening-using-patient-derived-tumor-xenografts-to-predict/)
- [BRAF mutation predicts sensitivity to MEK inhibition](https://scholariq.org/papers/braf-mutation-predicts-sensitivity-to-mek-inhibition/)
- [Epidermal Growth Factor Receptor Activation in Glioblastoma through Novel Missense Mutations in the Extracellular Domain](https://scholariq.org/papers/epidermal-growth-factor-receptor-activation-in-glioblastoma-through-novel/)
- [FGFR Genetic Alterations Predict for Sensitivity to NVP-BGJ398, a Selective Pan-FGFR Inhibitor](https://scholariq.org/papers/fgfr-genetic-alterations-predict-for-sensitivity-to-nvp-bgj398-a-selective-pan/)
- [Allosteric Inhibition of SHP2: Identification of a Potent, Selective, and Orally Efficacious Phosphatase Inhibitor](https://scholariq.org/papers/allosteric-inhibition-of-shp2-identification-of-a-potent-selective-and-orally/)

## Researcher topics

- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)
- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Fibroblast Growth Factor Research](https://scholariq.org/topics/fibroblast-growth-factor-research/)
- [Epigenetics and DNA Methylation](https://scholariq.org/topics/epigenetics-and-dna-methylation/)

## Researcher university

- [Broad Institute](https://scholariq.org/institutions/broad-institute/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.